Watson Pharmaceuticals: FDA Approves Generic of Teva's Plan B Emergency Contraceptive

Date : 07/13/2012 @ 9:21AM
Source : Dow Jones News
Stock : Actavis, Inc. (WPI)
Quote : 85.73  0.0 (0.00%) @ 2:05AM

Watson Pharmaceuticals: FDA Approves Generic of Teva's Plan B Emergency Contraceptive

Watson (NYSE:WPI)
Historical Stock Chart

5 Years : From Jan 2013 to Jan 2018

Click Here for more Watson Charts.
   By Melodie Warner 

Watson Pharmaceuticals Inc.'s (WPI) generic version of Teva Pharmaceutical Industries Ltd.'s (TEVA, TEVA.TV) Plan B One-Step emergency contraceptive obtained U.S. Food and Drug Administration approval.

Plan B One-Step, sometimes called the "day-after pill," is used to prevent pregnancy following unprotected intercourse or a known or suspected contraceptive failure.

Watson said it plans to immediately launch its product as Next Choice One Dose.

The company said market-researcher IMS Health puts U.S. sales of Plan B One-Step at $88 million for the year ending May 31.

In April, Watson reported its first-quarter earnings rose 22% as it recorded sharply higher revenue with a boost from new generic drugs and as its branded pharmaceuticals and distribution business also posted double-digit growth.

-Write to Melodie Warner at melodie.warner@dowjones.com

Latest WPI Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.